| Video
“Documentation” may mean different things to a lawyer and to a practitioner. How can practitioners best maintain standards of care? PAINWeek senior faculty member Jennifer Bolen, JD, offers her opinion.
| Video
Deborah Morrow, Pain Program Coordinator at the Eastern Oklahoma VA Center in Muskogee, explains the VA’s approach to pain care.Deborah Morrow, Pain Program Coordinator at the Eastern Oklahoma VA Center in Muskogee, explains the VA’s approach to pain care.
| Video
Dr. Mark Garofoli discusses a positive stride in advancing patient care and making efforts to ensure that lives within the national opioid crisis are saved and/or improved. One of those positive strides involves the FDA approval of abuse deterrent formulation (ADF) opioid medications, with the aim...
| Video
Of the different models of education emerging in the past decade, pain neuroscience education is a front runner. It can be used to decrease the focus on specific anatomical structures and reconceptualize the patient’s pain to focus more on recovery rather than causes of pain. It applies the...
| Video
Rising PAINWeek faculty members Courtney Kominek, PharmD, BCPS, CPE, and Abigail T. Brooks, PharmD, BCPS, talk about what they’ve learned in their careers, how they feel about what they do, and the importance of collaboration.
| Video
A chronic pelvic pain specialist, Jorge F. Carrillo, MD, discusses the challenges of understanding visceral and somatic pain, their presentations, and the organ systems involved. Symptoms may be confusing, and patients may have difficulty explaining their pain to a practitioner. And the practitioner...
| Video
The opioid crisis in America has resulted in many changes and challenges for clinicians who undertake the difficult field of pain management. Specifically, guidelines have been proposed and effectively adopted by regulators and insurers as quasi standards of care. This has created very real barriers...
| Video
Long-term migraine treatment may reduce the number of headaches per month. But it is enough? Botulinum toxin has also helped migraine sufferers. Botox is FDA approved for chronic migraine. Dr. Argoff says when Botox is combined with other medications, migraine occurrence per month is greatly reduced...
| Video
Guidelines. Meant to be helpful. But… they have both positive and negative impacts, and are sometimes misappropriated. Michael R. Clark, MD, MPH, MBA, talks about the good and bad of guidelines, and the importance of remembering that they are just that: a guide.
| Video
Michael C. Barnes, JD, MIEP, Principal Attorney at Sequel Legal, discusses his wishes for the future of pain management and drug policy. Does medical marijuana have a part in that future?